Acrivon Therapeutics, Inc. Common Stock (ACRV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Acrivon Therapeutics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.19x | -2.86x | -1.80x | -8.10x | -13.23x | -40.49x |
| P/B Ratio | 0.82x | 1.30x | 0.90x | 1.48x | -9.02x | -25.53x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.69x | 10.55x | 9.75x | 20.27x | 34.46x | 2.80x |
| Quick Ratio | 7.69x | 10.55x | 9.75x | 20.27x | 34.46x | 2.80x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.04x | 0.03x | -0.24x | -0.01x |
YoY = year-over-year change. Source: FMP..